http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20026133

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't|Research Support, U.S. Gov't, Non-P.H.S.
endingPage 9
issn 1465-5411
1465-542X
issueIdentifier 6
pageRange r881-9
publicationName Breast cancer research : BCR
startingPage r881
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a0eb2fadabf1dffb4d70280b760adba
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_cee975eeb88dd08d42f2e34d74513fab
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bab20bac5518c5206d9335ec201ac0b8
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_19a071c3f72f8edce110847889386fab
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e4e91c980f07112a07d7280a590fbe11
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9ef52f318ef45aa6720918b913776ce0
bibliographicCitation Namba R, Young LJ, Maglione JE, McGoldrick ET, Liu S, Wurz GT, DeGregorio MW, Borowsky AD, MacLeod CL, Cardiff RD, Gregg JP. Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ. Breast Cancer Res. 2005;7(6):R881–9. PMID: 16280035; PMCID: PMC1410776.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5e9663caa4209c3e1feda43b81fc002
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89394f291473dc769f4b2c75329a86c3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_305efa571f19c68f737ac577a42f0461
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0915a4cb104a4e5566e6363f3e35291a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_18c26b5c0f015201ac8fb2ffd4e442e9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ba6a46b7d9dc17642aff18319966693
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70d38cf9c3974e41a8d75fbb598edb15
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8acb920664b2e6c3aa5c488f8ad05402
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e3aabe9a2b08a803cf051ecef59377d7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b3ad38094547bb2e1ce7c6ae97511345
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_adaa0e033d47006615c9e09463c15b5d
date 2005-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/16280035
https://pubmed.ncbi.nlm.nih.gov/PMC1410776
https://doi.org/10.1186/bcr1317
isPartOf https://portal.issn.org/resource/ISSN/1465-5411
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21884
https://portal.issn.org/resource/ISSN/1465-542X
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ
discusses http://id.nlm.nih.gov/mesh/M0018586
http://id.nlm.nih.gov/mesh/M0328354
http://id.nlm.nih.gov/mesh/M0021024
http://id.nlm.nih.gov/mesh/M0305127
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8958
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9245
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3036505
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7164

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128610812
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128141778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129740575
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129769972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128121087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128713593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128543302

Total number of triples: 59.